S100A6
Protein S100-A6
Also known as: 2A9, CABP, CACY, PRA, S10A6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P06703
- Gene
- S100A6
- Ensembl
- ENSG00000197956
- Chromosome
- 1
- Canonical length
- 90 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21. This protein may function in stimulation of Ca2+-dependent insulin release, stimulation of prolactin secretion, and exocytosis. Chromosomal rearrangements and altered expression of this gene have been implicated in melanoma. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
90 residues, UniProt reviewed canonical sequence.
>P06703|S100A6
1 MACPLDQAIG LLVAIFHKYS GREGDKHTLS KKELKELIQK ELTIGSKLQD AEIARLMEDL
61 DRNKDQEVNF QEYVTFLGAL ALIYNEALKGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against S100A6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 4,483 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 4,483 nTPM
- urinary bladder: 3,605 nTPM
- kidney: 3,602 nTPM
- adipose tissue: 3,468 nTPM
- lung: 3,315 nTPM
- colon: 3,077 nTPM
Single-cell type
- colonocytes: 21,095 nCPM
- esophageal apical cells: 13,497 nCPM
- urothelial cells: 11,838 nCPM
- goblet cells: 11,783 nCPM
- ocular epithelial cells: 11,436 nCPM
- gastric progenitor cells: 11,252 nCPM
Immune cell
- neutrophil: 9,718 nTPM
- total PBMC: 8,344 nTPM
- classical monocyte: 6,082 nTPM
- basophil: 5,552 nTPM
- myeloid DC: 4,254 nTPM
- intermediate monocyte: 3,271 nTPM
Brain region
- hypothalamus: 483 nTPM
- thalamus: 456 nTPM
- white matter: 343 nTPM
- medulla oblongata: 327 nTPM
- midbrain: 259 nTPM
- spinal cord: 257 nTPM
ReferencesPubMed · IEDB
Publications for S100A6 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
1 publication
- S100A6 participates in initiation of autoimmune encephalitis and is under epigenetic control.
2023 · Brain Behav · RCR 0.5 · 5 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.64
- gnomAD pLI
- 0.18
- gnomAD missense Z
- 0.25
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- calcium ion binding
- calcium-dependent protein binding
- monoatomic ion transmembrane transporter activity
- protein homodimerization activity
- S100 protein binding
- tropomyosin binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of S100A6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads S100A6 as an antibody target. Whether an autoantibody or antibody against S100A6 could matter depends on whether native S100A6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
S100A6 is annotated at the cell surface, where native S100A6 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label S100A6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...